newsfeedback@fool.com (Eric Volkman) / Fool.com -GOOG
New Data Shows Higher Efficacy Rate for Pfizer and BioNTech Coronavirus Vaccine Candidate – The two companies plan to submit BNT162b2 for Emergency Use Authorization in the very near future. On Wednesday morning, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX)presented new data from a final efficacy analysis on their BNT162b2 vaccine candidate, and the news was very good. In a joint press release, the …
